A Case Report of Tinea Capitis in an Infant in the First Year of Life
February 2019
in “
BMC pediatrics
”
Studysummary This case report highlights the importance of accurately diagnosing and treating tinea capitis in infants to prevent recurrences and therapeutic failures.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
In 2019, Mandras et al. described a rare instance of tinea capitis (TC) in a 12-month-old infant, characterized by scalp lesions and hair loss. The infection, caused by Microsporum canis, was initially treated with griseofulvin for 2 months, but a relapse occurred 15 days after treatment. An additional month of treatment resulted in complete healing with no recurrence at a 3-month follow-up. This case underscores the necessity for precise diagnosis and treatment of TC, particularly in young children, and suggests that while griseofulvin is standard, other antifungals may also be considered based on safety, age, formulation, and cost.
